Abstract
Introduction
Interactive Voice Response (IVR) technology uses the telephone to collect patient reports. This study examined whether IVR adherence during a year-long clinical trial was related to subject retention in the trial.
Methods
As part of a randomized, double-blind, placebo-controlled study of daily multivitamin supplementation for recurrent aphthous stomatitis, 160 study participants were asked to make 1 weekly IVR call for the one-year study duration.
Results
The 114 subjects who completed the study made 90.5% of their expected number of IVR calls, as compared to 55.7% of expected calls made by the 46 subjects who withdrew prematurely (p<0.001). Subjects who successfully completed the study were also more likely to initiate their IVR calls as compared to subjects who withdrew from the study (p <0.001). A multivariable model incorporating different adherence variables was able to successfully predict retention status of more than 80% of subjects. IVR adherence during the first few weeks of study participation was strongly predictive of subsequent retention and successful completion of this one-year study.
Discussion
Subjects who withdrew prematurely had more missing data than study completers, even after accounting for period of study participation, potentially introducing bias into IVR results. Sub-optimal adherence to weekly IVR might provide an early signal of subsequent premature withdrawal in clinical trials. IVR adherence could be used as a screening tool during a trial period, to identify subjects most likely to stay on long clinical trials.
Conclusion
IVR adherence may be useful in anticipating retention in long-term clinical studies.
Keywords: Interactive Voice Response, IVR, Interactive Voice Response Systems, IVRS, retention, compliance, clinical research
Introduction
Interactive Voice Response (IVR) is an automated data collection tool in which study participants use their telephone keypad to answer pre-recorded questions. IVR is especially useful in long term studies involving large numbers of subjects. Data collection is less time and labor intensive for investigators, and less demanding for study participants, who can respond to the questionnaires remotely from a convenient location. Due to its many potential advantages, IVR is being increasingly used in clinical research [1, 2, 3].
The relative costs and benefits of electronic data capture such as IVR compared to paper reports completed off site has been debated. In a previous study of head and neck cancer patients undergoing radiation therapy [4], we demonstrated high concordance between paper diaries and IVR. However, paper diaries yielded greater adherence, though adherence indicators for paper diaries are less verifiable. Whereas some studies comparing paper and electronic diaries have concluded that electronic diaries are superior; others have found no difference or have presented a mixed picture of the relative merits of each method [5, 6]. It has been suggested that either method can be suitable for studies where discrete behaviors are being studied. On the other hand, electronic diaries may be preferable for examining within-day temporal dynamics or evaluating rapidly changing phenomena [7].
In the current study we used weekly IVR patient reports in a year-long clinical trial to evaluate whether IVR adherence was an anticipatory marker of a participant’s premature withdrawal from the study. We also examined whether IVR adherence in the first few weeks of study participation may predict subsequent retention on the study.
Methods
Subjects
This is a secondary analysis of data collected during a randomized, double-blind, placebo-controlled clinical trial of multivitamin supplementation for Recurrent Aphthous Stomatitis (an idiopathic ulcerative condition of the oral mucosa) [8]. The trial was conducted at the University of Connecticut Health Center, Farmington, CT, USA. 160 subjects were randomized to either a multivitamin supplement or placebo in a 1:1 ratio, and asked to take the study medication once a day for the 1 year duration of the study.
The sample size of 160 subjects was calculated based on the primary objectives of the parent clinical trial i.e. to evaluate the effect of daily multivitamin therapy on the number and duration of Recurrent Aphthous Stomatitis episodes. Specifically, we calculated study sample size based on 80% power, and 0.05 alpha, to detect at least a 65% probability that a randomly chosen person from the multivitamin arm has a superior outcome (fewer and/or shorter episodes) when compared to a randomly chosen person from the placebo arm. Based on these parameters, we estimated that a final sample size of at least 100 subjects (50 per arm) would be needed to achieve adequate power, after accounting for dropouts. Since this was a one-year study, we allowed for a relatively high drop-out rate by enrolling 160 subjects. One hundred and fourteen participants completed the year-long study and 46 withdrew before completing the study. The study was approved by the Institutional Review Board and all subjects provided written informed consent.
IVR Data Collection
Subjects were asked to call the IVR system (IVRS) once a week (Monday to Sunday) for the duration of the study, with a week’s period between successive calls. However, the IVRS was accessible to subjects at all times during study participation. If the IVRS had not received the call by 7 pm on Thursday of a given week, the subject received an automated reminder call, which also allowed him/her to complete the survey at that time. A second automated reminder call was made at 8 pm on Friday if the subject had still not called the IVRS. The IVR survey asked subjects if they had experienced any mouthsores, how many doses of study medication they had missed and about any illness or unusual stress experienced, all since the last call. Subjects responded to these questions by pressing numbers on the telephone keypad. On average, each call took about 1–2 minutes. Subjects were compensated US$5 for each weekly IVR call completed over the course of the study.
IVR Adherence and Subject Retention
The IVRS tracked the number of weekly IVR surveys completed by each subject, and whether the subject called the system or completed the survey during a system-initiated reminder call. For subjects who successfully completed the year-long study, the total number of expected calls was 52. For subjects who dropped out of the study, the total number of expected calls was the number of full weeks elapsed from the baseline visit to the date the subject made his/her last IVR call. The actual number of calls made by each subject was compared to the number of expected calls for that subject to calculate a compliance rate for each subject. A mean compliance rate was calculated for all 114 subjects who successfully completed the study and separately for all 46 subjects who dropped out. These compliance rates were compared using the generalized linear model for a binary outcome. This analytic approach was needed to be able to properly weight each subject by the number of observations provided (i.e. duration of study participation). We also examined the relationship between subject retention and the proportion of IVR surveys completed by each subject that were initiated by the subject, versus completing the survey during a system-initiated reminder call, using a chi square test. Further, the relationship between subject retention and promptness in completing the IVR calls was examined using a chi square test i.e. whether the survey was completed before the first reminder call or not. A multivariable model was used to examine the combined relationship of IVR adherence, call initiation, and call promptness, on subject retention. To examine the predictive utility of IVR adherence on subject retention during the first few weeks of the study, the proportion of IVR surveys done by completers and non-completers during their first six weeks of study participation was compared, using a chi square test.
Results
Interval between Successive IVR Calls
Subjects were generally compliant with the instruction to maintain a week’s period between IVR calls. For all IVR calls completed in successive weeks, the mean period between calls was 7.82 days. 76.5% of all calls occurred between 6 and 8 days of the previous call by the same subject. Only 2.9% of calls occurred within 4 days of the previous call by the same subject.
IVR Adherence and Subject Retention
The 114 subjects who completed the study made 90.5% of expected IVR calls as compared to 55.7% for the 46 subjects who withdrew from the study. Subjects who completed the study were more likely to complete their IVR calls compared to subjects who withdrew (p < 0.001), even after accounting for study condition (multivitamin vs placebo) and severity of illness (as measured by number of episodes of recurrent aphthous stomatitis reported by study subjects, over 70% of these episodes were also verified by clinical examination). Among subjects who withdrew from the study prematurely, exact duration of study participation showed no relationship to IVR adherence (p=0.48). Subjects who completed the study were also more likely to initiate their IVR calls (79.4% of completed calls) compared to subjects who withdrew (71.6%, p <0.001). Among the subjects who completed the study, 67.4% of calls were made promptly (defined as before the first reminder call), while among the subjects who withdrew prematurely, 60.1% of the calls were made promptly (p = 0.106). A multivariable model incorporating all 3 compliance variables (i.e. call adherence, call initiation, and call promptness) was able to correctly predict retention status of 80.5% of subjects. Of the 3 compliance variables in the multivariable model, the strongest individual predictor of retention status was call adherence (p<0.001). Call initiation alone (p=0.929) and call promptness alone (p=0.339) did not significantly predict retention status in this model.
Table 1 shows the cumulative adherence with completing IVR calls in the first 6 weeks of the study for study completers and non-completers. This period represents approximately the first 10% of the 52-week study duration. At each weekly time-point, there was a statistically significant difference between the two groups in adherence to completing IVR calls. Although cumulative adherence dropped in both groups over the 6 week period, the drop was much more pronounced in the subjects who ultimately withdrew from the study. 10 subjects made 1 call or less during the first 4 weeks of study participation; of these, 9 subjects did not complete the study, with 7 of them withdrawing after the first 4 weeks.
Table 1.
Week | Number of subjects who completed all expected IVR calls (% of total number of subjects in that group) | P-Value | |
---|---|---|---|
Completers (n=114) | Non-completers (n=46) | ||
1 | 114 (100%) | 40 (87%) | <0.001 |
2 | 109 (96%) | 33 (72%) | <0.001 |
3 | 103 (90%) | 29 (63%) | <0.001 |
4 | 101 (89%) | 28 (61%) | <0.001 |
5 | 96 (84%) | 21 (46%) | <0.001 |
6 | 89 (78%) | 21 (46%) | <0.001 |
Note: IVR adherence presented at each week is cumulative i.e. data for each weekly time-point includes all IVR calls up to that time-point.
Discussion
IVR is being increasingly used for data collection due to its many advantages including timestamped data collection (as compared to paper forms which can be backfilled). We found that subjects who withdrew prematurely from the study completed fewer IVR calls (and therefore had more missing data) than those who completed the study, even after accounting for the period of study participation. This can introduce a potential source of bias into IVR results. However, a similar phenomenon may occur with other forms of data collection such as paper diaries; this is a fertile area for future study.
Subject retention in lengthy clinical trials is a significant challenge faced by researchers in all clinical fields. We found that weekly IVR adherence predicted completer status. A multivariable model incorporating different adherence variables was able to successfully predict retention status of more than 80% of subjects. Interestingly, IVR adherence during the first few weeks of study participation was strongly predictive of subsequent retention and successful completion of this one-year study. These findings indicate that IVR adherence could be used as a screening tool during a trial period of a few weeks, to identify subjects most likely to stay on long clinical trials. This would in turn save significant resources and speed up study completion. However, it should be noted that such selection of subjects may introduce some selection bias which could affect the external validity of the study results. Additional studies, including studies with non-IVR control groups, may help determine whether IVR and other electronic data capture methods not only predict, but also promote subject retention. Future studies should also measure person factors such as conscientiousness and motivation as possible third factors in the associations we report here. Finally, additional research is needed to determine whether these results generalize to other populations.
Conclusion
Our findings suggest that adherence to IVR and other electronic data capture methods may predict the subsequent completer status of individuals in lengthy clinical trials.
Acknowledgments
Research support provided by the Patrick and Catherine Weldon Donaghue Medical Research Foundation, NIH training grant T32 DE007302 awarded to the UConn School of Dental Medicine and NIH grant M01 RR06192 awarded to the UConn General Clinical Research Center. The authors thank Ms. Linda Choquette and Ms. Harriet Zawistowski for their contributions. The authors declare no conflicts of interest.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Kaminer Y, Litt MD, Burke RH, Burleson JA. An Instructive Voice Response (IVR) system for adolescents with alcohol use disorders: A Pilot Study. American Journal of Addiction. 2006;15 (Suppl 1):122–125. doi: 10.1080/10550490601006121. [DOI] [PubMed] [Google Scholar]
- 2.Kranzler HR, Abu-Hasaballah K, Tennen H, Feinn R, Young K. Using daily Interactive Voice Response technology to measure drinking and related behaviors in a pharmacotherapy study. Alcohol Clin Exp Res. 2004;28:1060–1064. doi: 10.1097/01.alc.0000130806.12066.9c. [DOI] [PubMed] [Google Scholar]
- 3.Abu-Hasaballah K, James A, Aseltine RH., Jr Lessons and pitfalls of Interactive Voice Response in medical research. Contemporary Clinical Trials. 2007;28:593–602. doi: 10.1016/j.cct.2007.02.007. [DOI] [PubMed] [Google Scholar]
- 4.Blondin JM, Abu-Hasaballah KS, Tennen H, Lalla RV. Electronic versus paper diaries: a pilot study of concordance and adherence in head and neck cancer patients receiving radiation therapy. Head and Neck Oncology. 2010;2:29. doi: 10.1186/1758-3284-2-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.McKenzie S, Paty J, Grogan D, Rosano M, Curry L, Sciarappa K, Hufford M. Proving the e-diary dividend. Applied Clinical Trials. 2004;13:54–68. [Google Scholar]
- 6.Weiler K, Christ AM, Woodworth GG, Weiler RL, Weiler JM. Quality of patient-reported outcome data captured using paper and interactive voice response diaries in an allergic rhinitis study: Is electronic data capture really better? Annals of Allergy, Asthma & Immunology. 2004;92:335–339. doi: 10.1016/S1081-1206(10)61571-2. [DOI] [PubMed] [Google Scholar]
- 7.Tennen H, Affleck G, Coyne JC. Paper and plastic in daily diary research: Comment on Green, Rafaeli, Bolger, Shrout, and Reis (2006) Psychological Methods. 2006;11:112–118. doi: 10.1037/1082-989X.11.1.112. [DOI] [PubMed] [Google Scholar]
- 8.Lalla RV, Choquette LE, Feinn RS, Zawistowski H, Latortue MC, Kelly ET, Baccaglini L. A Randomized, double-blind, placebo-controlled trial of daily multivitamin therapy for recurrent aphthous stomatitis. Journal of the American Dental Association. doi: 10.14219/jada.archive.2012.0179. In Press. [DOI] [PMC free article] [PubMed] [Google Scholar]